Aurora Technology Acquisition Corp. (ATAK) Signs Non-Binding LOI with DIH Technology
by Marlena Haddad on 2022-12-12 at 4:31pm

Aurora Technology Acquisition Corp. (NASDAQ:ATAK) announced this afternoon that it has signed a non-binding letter of intent (LOI) to combine with robotics company DIH Technology Ltd.

Under the terms of the LOI, DIH’s shareholders will roll 100% of their equity into the combined public company. The parties have not yet released details on the transaction, but expect to announce further information when a definitive agreement is executed, which is expected to occur before January 31, 2023.

Beijing, China-based DIH develops robotics for rehabilitation and virtual reality for human performance. The company owns technology brands such as HOCOMA and Motek, with more than 4,500 robots and advanced VR-based movement systems installed in 70 countries. DIH’s principal customers include research centers, innovative rehabilitation hospitals, and healthcare clinics.

“We believe the combination with ATAK will facilitate our launch as a public company with strong corporate governance, expand our capital market expertise, and enhance our strategic investment capabilities, including M&A,” Jason Chen, CEO and Chairman of DIH’s board of directors noted in today’s press release.

Aurora Technology announced the pricing of its $200 million IPO in February 2022 and set out to combine with a high-growth technology company based in North America or Asia. The SPAC prioritized target companies founded by Asian or Asian-American entrepreneurs who are building a global enterprise focused on artificial intelligence, blockchain, quantum computing, and electric vehicles.  Aurora Technology is led by CEO and Chairman Zachary Wang, COO and Co-Vice Chairwoman Cathryn Chen, and CFO and Co-Vice Chairman Yida Gao.

The SPAC has a completion deadline of February 9, 2023, but has the ability to extend two times by an additional three months each by depositing $0.10/share in its trust account for each extension.

Since Aurora Technology’s deal is not at the “definitive agreement” stage and is still just a non-binding LOI, SPACInsider will not consider this deal fully “announced”. As such, it will remain in the “Searching” category until a definitive agreement is signed.

 

 

Aurora Technology Acquisition Corp. (ATAK) Signs Non-Binding LOI with DIH Technology
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 7:51pm

Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....

by Nicholas Alan Clayton on 2025-07-01 at 7:47pm

Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....

by Nicholas Alan Clayton on 2025-07-01 at 7:19pm

1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...

by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved